TALAPRO-2 study infographic
Our recent In Focus highlighted the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer. Take a look at the infographic summarizing the study below:
This content is part of our Publication In Focus on TALAPRO-2 – view more content from this feature by clicking here.